Printer Friendly

BARR LABORATORIES AND CIRCA PHARMACEUTICALS SETTLE LAWSUIT

 POMONA, N.Y., June 3 /PRNewswire/ -- Barr Laboratories, Inc. (AMEX: BRL), and Circa Pharmaceuticals, Inc. (AMEX: RXC), today announced that they have agreed to settle the lawsuit between them (Barr v. Circa) which has been pending in the United States District Court in New Jersey since 1991. The litigants said that they withdrew their claims and counterclaims because the potential benefits of the litigation did not outweigh the estimated costs of going forward.
 Circa has agreed to pay Barr $690,000 which will cover Barr's legal fees and expenses and other costs associated with the prosecution of Barr's claims.
 -0- 6/3/93
 /CONTACT: Harold Cohen of Barr, 914-362-2823; or Melvin Sharoky, M.D., of Circa, 516-842-8383/
 (BRL RXC)


CO: Barr Laboratories, Inc.; Circa Pharmaceuticals, Inc. ST: New York, New Jersey IN: MTC SU:

GK-OS -- NY063 -- 5016 06/03/93 13:08 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 3, 1993
Words:143
Previous Article:ROTTLUND REPORTS HIGHER EARNINGS FOR FOURTH QUARTER AND 12 MONTHS
Next Article:PROCTER & GAMBLE TAKES STEPS TO ENCOURAGE CHILD SAFETY; SCOPE TO DEVELOP CHILD-RESISTANT PACKAGING
Topics:


Related Articles
BARR RESPONDS TO FDA LAWSUIT
BARR LABORATORIES SETTLES 1992 SHAREHOLDER ACTION
CIRCA ANNOUNCES SETTLEMENT OF SUIT AGAINST FORMER PRESIDENT
BARR LABORATORIES CHALLENGING PROZAC PATENTS
Cephalon files narcolepsy patent infringement lawsuit.
ADDERALL XR(R) - Shire Files Legal Suit Against Barr Laboratories and Impax Laboratories for Infringement of U.S. Patent No. 6,913,768.
ADDERALL XR(R) - Shire Files Legal Suit Against Barr Laboratories and Impax Laboratories for Infringement of U.S. Patent No. 6,913,768.
ADDERALL XR(R) - Impax Files Suit Against Shire for Invalidity and Non-Infringement of US Patent No. 6,913,768.
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits.
United States Court of Appeals denies rehearing request in dismissal of Tamoxifen Citrate antitrust lawsuits.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters